THERMO FISHER SCIENTIFIC INC.·4

Nov 14, 4:47 PM ET

Lagarde Michel 4

4 · THERMO FISHER SCIENTIFIC INC. · Filed Nov 14, 2025

Insider Transaction Report

Form 4
Period: 2025-11-13
Lagarde Michel
Executive Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-13$253.99/sh+4,638$1,178,00628,117.909 total
  • Sale

    Common Stock

    2025-11-13$594.42/sh4,638$2,756,92023,479.909 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-11-134,6380 total
    Exercise: $253.99Exp: 2026-02-26Common Stock (4,638 underlying)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $594.36 to $594.88, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT